2nd Quarter - Report

SIDLEY AUSTIN LLP for SUNOVION PHARMACEUTICALS INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Access to perscription drugs and payment/reimbursement related issues, including patient access under Medicare Part D

LobbyistCovered position, as disclosed
PATRICIA LOUISE DELOATCHE Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, and Legislative Assistant, Rep. Mike Bilirakis
STEPHANIE P HALES N/A
DARON WATTS N/A

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.